<DOC>
	<DOCNO>NCT00060320</DOCNO>
	<brief_summary>RATIONALE : The herbal supplement black cohosh may effective relieve hot flash woman . PURPOSE : Randomized phase III trial determine effectiveness black cohosh relieve hot flash woman breast cancer risk develop breast cancer .</brief_summary>
	<brief_title>Black Cohosh Treating Hot Flashes Women Who Have Who Are At Risk Developing Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare efficacy black cohosh v placebo diminish hot flash activity woman breast cancer OR concern take hormone fear breast cancer . - Determine whether continued use drug patient lead prolonged reduction hot flash score minimal toxic effect . - Correlate reduction hot flash score improvement quality life relate outcomes patient treat drug . - Determine toxic effect drug patient . - Determine whether abnormal sweat decreased patient treat drug . OUTLINE : This randomize , double-blind , placebo-controlled , crossover study . Patients stratify accord age ( 18 49 v 50 ) , current tamoxifen use ( yes v v unknown ) , current raloxifene use ( yes v v unknown ) , current aromatase inhibitor use ( yes v ) , duration hot flash symptom ( less 9 month vs 9 month ) , average frequency hot flash per day ( 2-3 v 4-9 v 10 ) . Patients randomize 1 2 treatment arm . - Arm I : Patients receive oral black cohosh twice daily 4 week . - Arm II : Patients receive oral placebo twice daily 4 week . All patient cross arm receive treatment 4 week . After completion crossover treatment , patient may opt receive open-label black cohosh additional 8 week . Patients complete hot flash diary daily baseline 8-week double-blind study , daily 8 week optional open-label treatment . Patients opt receive open-label black cohosh follow 6 month , 1 year , 2 year . PROJECTED ACCRUAL : A total 110 patient ( 55 patient per arm ) accrue study within 6-11 month .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Hot Flashes</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : History breast cancer OR concern take hormone fear breast cancer No current active disease No current evidence malignant disease Bothersome hot flash Patientreported occurrence least 14 time per week sufficient severity make patient desire therapeutic intervention Hormone receptor status : PATIENT CHARACTERISTICS : Age 18 Sex Female Performance status ECOG 01 Life expectancy At least 6 month Other Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception Able complete questionnaire alone assistance PRIOR CONCURRENT THERAPY : Chemotherapy More 4 week since prior antineoplastic chemotherapy No concurrent antineoplastic chemotherapy doubleblind portion study Endocrine therapy More 4 week since prior androgen , estrogen , progestational agent More 2 week since prior dehydroepiandrosterone ( DHEA ) hot flash No concurrent androgen , estrogen , progestational agent doubleblind portion study No concurrent DHEA hot flash Concurrent tamoxifen , raloxifene , aromatase inhibitor allow provided patient start drug least 4 week prior study entry plan continue drug throughout doubleblind portion study Other More 2 week since prior antidepressant More 2 week since prior agent treat hot flash ( e.g. , clonidine Bellergals ) No prior black cohosh No concurrent antidepressant doubleblind portion study No concurrent agent treat hot flash ( e.g. , clonidine Bellergals ) Concurrent vitamin E and/or soy allow provided patient stable dose least 1 month prior study entry plan continue dose throughout study duration No concurrent oral herbal therapy therapeutic herbal tea tincture except beverage tea ( e.g. , chamomile , ginger , peppermint , lemongrass , fruitbased tea )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>stage IV breast cancer</keyword>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
	<keyword>hot flash</keyword>
</DOC>